MediciNova to Receive $2.5 Million Payment From Kissei Pharmaceutical Co. Ltd …
MarketWatch (press release) Ltd., a pharmaceutical company traded on the Tokyo Stock Exchange (4547), will pay MediciNova $2.5 million, within 30 days, to support further clinical development of MN-221 for the treatment of acute exacerbations of asthma or chronic obstructive … |
View full post on asthma – Google News